Bank of America’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bank of America’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-141,340	Closed	-$6.57M	–	8117
2023 Q2	$6.57M	Buy	141,340 +71,984	+104%	+$2.49M	﹤0.01%	3130
2023 Q1	$1.99M	Buy	69,356 +39,278	+131%	+$1.16M	﹤0.01%	4352
2022 Q4	$938K	Buy	30,078 +13,611	+83%	+$444K	﹤0.01%	4899
2022 Q3	$333K	Buy	16,467 +4,271	+35%	+$77.8K	﹤0.01%	5674
2022 Q2	$189K	Sell	12,196 -227	-2%	-$3.9K	﹤0.01%	6137
2022 Q1	$237K	Sell	12,423 -85,405	-87%	-$1.52M	﹤0.01%	6369
2021 Q4	$2.48M	Buy	97,828 +96,650	+8,205%	+$2.83M	﹤0.01%	4347
2021 Q3	$38K	Buy	+1,178	New	+$40.1K	﹤0.01%	7171

Bank of America's DICE Position: Q3 2023 in Review

Bank of America sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 141,340 shares — an estimated $6.57M sold.

Bank of America first reported a position in DICE in Q3 2021 and held it in 8 quarters. The position peaked at $6.57M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Bank of America reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Bank of America sold 141,340 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $6.57M.
Bank of America first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
Bank of America's DICE Therapeutics, Inc. Common Stock position peaked at $6.57M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.